SK bioscience Co.,Ltd. · KRX:302440
SK bioscience Co.,Ltd. shareholders
SK bioscience Co.,Ltd. on 6ix: holders from US fund reports. Largest: Vanguard Total International Stock Index Fund, iShares Core MSCI Emerging Markets ETF and Vanguard Developed Markets Index Fund. Each with its filing.
| Holder | Shares | % of SK bioscience Co.,Ltd. | Change | As of |
|---|---|---|---|---|
| Vanguard Total International Stock Index Fund | 373K | −9,627 | Jul 31, 2026 | |
| iShares Core MSCI Emerging Markets ETF | 278K | +3,896 | May 31, 2026 | |
| Vanguard Developed Markets Index Fund | 232K | −19,751 | Jun 30, 2026 | |
| Vanguard Ftse All-World Ex-Us Index Fund | 57,312 | −1,841 | Jul 31, 2026 | |
| Emerging Markets Core Equity 2 Portfolio | 51,737 | +9,761 | Jul 31, 2026 | |
| Schwab International Equity ETF | 47,767 | +1,352 | May 31, 2026 | |
| iShares Core MSCI Total International Stock ETF | 42,401 | +512 | Jul 31, 2026 | |
| Vanguard Pacific Stock Index Fund | 28,401 | no change | Jul 31, 2026 | |
| The Emerging Markets Small Cap Series | 27,511 | new | Jul 31, 2026 | |
| Fidelity Total International Index Fund | 24,246 | +8,747 | Jul 31, 2026 |